First case report in Latin America: Oral treatment of multidrug-resistant tuberculosis with delamanid and bedaquiline in combination with linezolid, moxifloxacin and clofazimine following a DRESS syndrome in a peruvian patient

Pecho-Silva, S.; Navarro-Solsol, A.C.

dc.contributor.author	Pecho-Silva, S.
dc.contributor.author	Navarro-Solsol, A.C.
dc.date.accessioned	2025-10-31T18:32:46Z
dc.date.available	2025-10-31T18:32:46Z
dc.date.issued	2021
dc.identifier.uri	https://hdl.handle.net/20.500.12805/4765
dc.description.abstract	The World Health Organization recommends the use of oral medications for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB).Citation However, few countries have adopted these recommendations, either due to lack of medication or because of outdated local recommendations, as in the case of Peru.Citation The combination of some medications for the treatment of MDR TB such as delamanid (Dlm) with bedaquiline (Bdq) has been associated with a potential risk of cardiovascular symptoms such as prolongation of the QT interval corrected by Fridericia interval (QTcF)...	en_US
dc.description.sponsorship	The authors would like to thank Delia Loayza Tamayo, Félix Alcántara Virú, and Javier Torres Valencia for their generous assistance during the treatment of the patient. The authors would like to thank Partners In Health – Perú for the donation of medicines: delamanid, clofazimine, bedaquiline.
dc.format	application/pdf
dc.language.iso	eng
dc.publisher	Elsevier
dc.relation.ispartof	urn:issn:2531-0437
dc.rights	https://purl.org/coar/access_right/c_abf2
dc.rights.uri	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subject	SDG 3	en_US
dc.subject	Tuberculosis Treatment and Diagnostic Innovations	en_US
dc.subject	Innovative Approaches to Multidrug-Resistant Tuberculosis Treatment	en_US
dc.title	First case report in Latin America: Oral treatment of multidrug-resistant tuberculosis with delamanid and bedaquiline in combination with linezolid, moxifloxacin and clofazimine following a DRESS syndrome in a peruvian patient	en_US
dc.type	https://purl.org/coar/resource_type/c_545b
dc.identifier.doi	https://doi.org/10.1016/j.pulmoe.2020.03.005
dc.subject.ocde	https://purl.org/pe-repo/ocde/ford#3.03.08
dc.type.other	Letter to the editor
dc.identifier.journal	Pulmonology
dc.type.version	https://purl.org/coar/version/c_970fb48d4fbd8a85

Files in this item

Files	Size	Format	View
There are no files associated with this item.

This item appears in the following Collection(s)

Cartas al editor [122]

Show simple item record

Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2